| Pilot study with a glutamine-supplemented enteral formula in critically ill infants. | |
| | |
MedLine Citation:
|
PMID: 10488597 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Seriously ill infants often display protein-calorie malnutrition due to the metabolic demands of sepsis and respiratory failure. Glutamine has been classified as a conditionally essential amino acid, with special usefulness in critical patients. Immunomodulation, gut protection, and prevention of protein depletion are mentioned among its positive effects in such circumstances. With the intent of evaluating the tolerance and clinical impact of a glutamine supplement in seriously ill infants, a prospective randomized study was done with nine patients. Anthropometric and biochemical determinations were made, and length of stay in the intensive care unit (ICU), in the hospital, and under artificial ventilation, and septic morbidity and mortality were tabulated. Infants in the treatment group (n = 5) were enterally administered 0.3 g/kg of glutamine, whereas controls received 0.3 g/kg of casein during a standard period of five days. Septic complications occurred in 75% of the controls (3/4) versus 20% of the glutamine-treated group (1/5, p < or = 0.10), and two patients in the control group died of bacterial infections (50% vs. 0%, p < or = 0.10). Days in the ICU, in the hospital, and with ventilation numerically favored glutamine therapy, although without statistical significance. The supplements were usually well tolerated, and no patient required discontinuation of the program. The conclusion was that glutamine supplementation was safe and tended to be associated with less infectious morbidity and mortality in this high-risk population. |
| | |
Authors:
|
E Barbosa; E A Moreira; J E Goes; J Faintuch |
Related Documents
:
|
16585307 - Treated hypotension is associated with neonatal morbidity and hearing loss in extremely... 21813927 - Congenital myotonic dystrophy with asymptomatic mother. 21973247 - Mortality trends in fiji. 4038547 - Maternal and perinatal morbidity resulting from placenta previa. 8556847 - Words as invitations to form categories: evidence from 12- to 13-month-old infants. 23106737 - Neural correlates of perceptual narrowing in cross-species face-voice matching. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Revista do Hospital das Clínicas Volume: 54 ISSN: 0041-8781 ISO Abbreviation: Rev Hosp Clin Fac Med Sao Paulo Publication Date: 1999 Jan-Feb |
Date Detail:
|
Created Date: 1999-12-13 Completed Date: 1999-12-13 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0415246 Medline TA: Rev Hosp Clin Fac Med Sao Paulo Country: BRAZIL |
Other Details:
|
Languages: eng Pagination: 21-4 Citation Subset: IM |
Affiliation:
|
Hospital Infantil Joana de Gusmão, Department of Nutrition, Federal University of Santa Catarina. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Child, Preschool Critical Illness* Dietary Supplements* Enteral Nutrition / methods* Female Glutamine / administration & dosage* Humans Infant Intensive Care Units, Pediatric Male Pilot Projects Prospective Studies |
| Chemical | |
Reg. No./Substance:
|
56-85-9/Glutamine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Detection of codon 12 mutation in the K-ras oncogene in pancreatic tumors.
Next Document: Clinical use of growth hormone and glutamine in short bowel syndrome.